Top Markets
Coin of the day
BioMark Diagnostics Inc. BioMark Diagnostics Inc.

BioMark Diagnostics Inc.

BUX
Rang in Aktien #26699
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Aktienkurs
$0.36696844
Marktkapitalisierung
$38.56M
Veränderung (1 Tag)
-13.79%
Veränderung (1 Jahr)
45.45%
Land
CA
Handel BioMark Diagnostics Inc. (BUX)

Kategorie

Dividendenrendite-Verlauf für BioMark Diagnostics Inc. (BUX)
Dividendenrendite (TTM) von BioMark Diagnostics Inc. (Aktienkürzel: BUX) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für BioMark Diagnostics Inc. (BUX) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber